Salma Sabbour
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer (NCT03575793) | Salma Sabbour | 2018-09-06 |
Track Salma Sabbour automatically
Every clearance here is in the API, with alerts when new ones post.